The Valley Desk

NCT04165070 · Interventional trial

KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Carcinoma, Non-Small-Cell Lung

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov